欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号LV/H/0220/001
药品名称Parmenol 1.5 mg/ml oral solution
活性成分
    • Butamirate citrate 1.5 mg/l
剂型Oral solution
上市许可持有人Medochemie Limited 1-10 Constantinoupoleos Street Limassol, 3011 Cyprus
参考成员国 - 产品名称Latvia (LV)
互认成员国 - 产品名称
    • Malta (MT)
      Parmenol 1.5mg/ml oral solution
    • Estonia (EE)
    • Bulgaria (BG)
      Parmenol
    • Cyprus (CY)
      Parmenol 1.5mg/ml πόσιμο διάλυμα
    • Slovakia (SK)
许可日期2022/06/16
最近更新日期2025/01/24
药物ATC编码
    • R05DB13 butamirate
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase